Exagen Inc - Multiplikator nilai perusahaan marang pendapatan XGN

Logo perusahaan publik Exagen Diagnostics (XGN)

Patent protection for autoimmune disease tests creates a moderate barrier for competitors for Exagen Inc. (XGN). The business relies on its own medical complex, outsourcing couriers and cloud services to external partners. The efficiency of delivering biomaterials to the hub guarantees diagnostic accuracy. The company's valuation via EV/Sales reflects demand dynamics, with the metric holding at 1350.21.

XGN: Nilai perusahaan marang pendapatan Exagen 23.11.2025 - 20.11.2026

XGN (Exagen Inc): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
- rincian nilai pasar emiten:
Pambiji fundamental perusahaan:Exagen Inc.
Produk asli Exagen

To minimize fundamental risks, investors select assets with a stable ratio of market capitalization to operating revenues. This indicator compares business value to revenue, excluding the impact of debt load to assess pure technological potential. For Exagen Inc. (XGN), this is critical, as pressure from insurance companies limits the final margins of diagnostic tests. By analyzing the company's price-to-sales ratio, one can determine if the asset is overbought. High values for this metric signal inflated market expectations regarding future growth rates.

Pesaing langsung

A (Agilent) - Rasio nilai perusahaan marang pendapatan|DGX (Quest Diagnostics) - Nilai perusahaan marang pendapatan|Illumina Inc (ILMN) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan EXAS|Revvity, Inc. (RVTY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales BIO|NNNN (Anbio Biotechnology) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales SHC (Sotera Health)|Quidel Corporation (QDEL) - Multiplikator nilai perusahaan marang pendapatan|OPK - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - Multiplikator EV/Sales|Cytek Biosciences (CTKB) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales OSUR|Rasio total nilai perusahaan marang pendapatan MDxHealth Inc.|Rasio nilai perusahaan marang pendapatan Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Multiplikator nilai perusahaan marang pendapatan|Insight Molecular Diagnostics Inc - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan trinitybiotech.com|PRPH (ProPhase) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AIMD|Nilai perusahaan marang pendapatan CODX|Multiplikator nilai perusahaan marang pendapatan heartsciences.com HSCS|Rasio nilai perusahaan marang pendapatan Biomerica Inc. (BMRA)|Rasio total nilai perusahaan marang pendapatan Cardio Diagnostics Holdings|Multiplikator EV/Sales ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Multiplikator nilai perusahaan marang pendapatan|bluejaydx.com - Multiplikator EV/Sales|Aspira Women's Health - Koefisien nilai perusahaan marang pendapatan|AXDX (Accelerate Diagnostics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan CENTOGENE, N.V.|Rasio nilai perusahaan marang pendapatan enzo.com|Multiplikator EV/Sales Fresh2 Group Limited|Multiplikator EV/Sales GENE|23andMe Holding Co. - Rasio nilai perusahaan marang pendapatan|Psychemedics Inc - Nilai perusahaan marang pendapatan